Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Talon Therapeutics Inc.

Division of Spectrum Pharmaceuticals Inc.
www.talontx.com

Latest From Talon Therapeutics Inc.

Deals Shaping The Medical Industry, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Deals Of The Week: Tire-Kicking Season Continues Full-Swing

As Roche’s reported interest in buying rare-disease specialist Alexion faded, new suitors popped up for oncology specialist Onyx. Plus news on deals between Spectrum and Talon, Pfizer and Sequella, Medtronic and Amgen, and a new direction for Rexahn.

BioPharmaceutical Medical Device

Spectrum Bets On Marqibo In NHL With Low-Priced Talon Acquisition

Spectrum gains an approved drug with the deal and aims for label expansion. Talon’s high-profile investors are counting on an increase in Spectrum share price and post-acquisition milestones to break even.

BioPharmaceutical Deals

Is The Time Finally Right For Bispecific Antibodies?

Merck, Lilly, Gilead and Celgene are among the companies striking deals that involve bispecific antibodies. The novel dual-acting drugs have been in development since the 1980s with little success, yet big pharma believes they may finally be coming of age.

Clinical Trials Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
  • Therapeutic Areas
  • Cancer
  • Dermatology
  • Alias(es)
  • Hudson Health Sciences Inc.
  • Hana Biosciences Inc.
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Spectrum Pharmaceuticals Inc.
  • Senior Management
  • Steven Deitcher, MD, Pres. & CEO
    Craig W Carlson, SVP, CFO
  • Contact Info
  • Talon Therapeutics Inc.
    Phone: (650) 588-6404
    400 Oyster Point Blvd.
    Ste. 200
    South San Francisco, CA 94080
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register